Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-FR Version v4-FR
Language French French
Date Updated 2023-07-13 2023-05-19
Drug Identification Number 02396467 02396467
Brand name APO-MELOXICAM APO-MELOXICAM
Common or Proper name MELOXICAM, MELOXICAM,
Company Name APOTEX INC APOTEX INC
Ingredients MELOXICAM MELOXICAM
Strength(s) 1.5G 1.5G
Dosage form(s) SUSPENSION SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 180 mL 180 mL
ATC code
ATC description
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-04-04 2023-04-04
Estimated end date 2023-07-14 2023-06-16
Actual end date 2023-07-07
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments 32 mL available 100 mL available
Health Canada comments